Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Once-daily ARB for high blood pressure. | Long-acting ARB, hugely popular in India. |
| Body system | Blood Pressure | Blood Pressure |
| Drug class | Angiotensin receptor blockers | Angiotensin receptor blockers |
| Supply | Prescription only | Prescription only |
| Main uses | High blood pressure | High blood pressure, Reducing cardiovascular risk |
| How it works | Relaxes blood vessels by blocking angiotensin II. | Blocks the receptor for a hormone that tightens blood vessels. |
| Starts working | Hours; full effect in 2–4 weeks | — |
| Half-life | 13 hours | About 24 hours |
| Typical adult dose | 10–20 mg once a day, up to 40 mg. | 20–80 mg once a day. |
| Forms | Tablet, Combination tablets | Tablet, Combination tablets |
| Common side effects | Dizziness, Headache, Tiredness, Back pain | Dizziness, Back pain, Sinus symptoms |
| Serious side effects | High potassium, Kidney problems, Severe low blood pressure, Sprue-like bowel disease (rare, with chronic use) | High potassium, Kidney decline, Angioedema (rare) |
| Don't take if | Pregnancy; Severe liver failure; Bile duct obstruction; Diabetes with aliskiren | Pregnancy; Biliary obstruction; Severe liver impairment; Taking aliskiren if diabetic |
| Alcohol | Best to limit. Alcohol may increase dizziness. | Best to limit. Alcohol can lower blood pressure further. |
| Pregnancy | Usually avoidedARBs can harm the baby's kidneys in the second and third trimesters; stop in pregnancy. | Usually avoidedContraindicated in the second and third trimesters. |
| Breastfeeding | Usually avoidedNot recommended while breastfeeding, especially in newborns. | Usually avoidedAvoid. |
| In use since | — | 1998 |
| Brand names | United States: BenicarUnited Kingdom: OlmetecIndia: Olmezest, Olmat | United States: MicardisUnited Kingdom: MicardisIndia: Telma, Telmikind, Telsartan |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | C09CA08 | C09CA07 |
Taken together
- MajorOlmesartan + Telmisartan: Dual blockade of the renin–angiotensin system
Combining ACE inhibitors, ARBs or sacubitril–valsartan raises the risk of high potassium, low blood pressure and kidney injury. Sacubitril–valsartan within 36 hours of an ACE inhibitor risks dangerous swelling (angioedema).